Sort by
Refine Your Search
-
Category
-
Field
-
The Department of Chemistry invites applicants for a PhD fellowship in computational homogenous catalyst discovery. Start date is 1.9.2025 or as soon as possible thereafter. The project The project
-
, Section for Environmental Chemistry and Physics, jch@plen.ku.dk , phone: +4535332456. The PhD programme Depending on your level of education, you can undertake the PhD programme as either: Option A: A
-
of Health and Medical Sciences. The PhD study must be completed in accordance with The Ministerial Order on the PhD programme (2013) and the Faculty’s rules on achieving the degree. The PhD student is
-
We are seeking an outstanding candidate for a PhD fellowship in the field of computational fluid and solid mechanics. The fellowship will start on September 1st, 2025, or as soon as possible after
-
We are looking for a creative and curious researcher for a post doc position in infection-organoid biology. The position is for 17 months, with start date 01.08.2025. You will get to explore how
-
collaboration, as part of the employment process at the University of Copenhagen. Notice: In the following description of the PhD programmes, some references are made to SCIENCE websites The PhD programme
-
The Novo Nordisk Foundation Quantum Computing Programme (NQCP) is establishing a talented and diverse international team to create a cutting-edge quantum programme in the heart of Copenhagen
-
more than 1300 Danish 6-11-year-old children. This included food and nutrition intervention components in the form of a school lunch programme, activities in the local supermarkets and SFO and practical tools
-
organising and conducting their own research project (under supervision). The programme culminates in the submission of a PhD thesis, which the student must defend in public. The programme is prescribed to 180
-
sciences and advancing vaccine development. NIVI-R conducts scientific research, while NIVI-D works to quickly turn that research into new vaccine candidates. NIVI-D accelerates clinical trials (phases 1 and